Takashi Futami
Associate Investment Director @ Astellas Venture Management
Takashi Futami is a seed investor at Astellas Venture Management focused on Medical and Biopharma. Mr. Futami joined Astellas Venture Management in Oct 2013. Prior to joining AVM, he worked as a Senior Researcher at Astellas Pharma Inc. He served as a team leader at Oncology Labs of Astellas Pharma, and led a drug discovery research and preclinical development of kinase inhibitor programs in oncology therapeutics area. He also hasexperiences of collaboration with several institution like The University of Tokyo Hospital, Metabolex Inc. etc.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Takashi Futami invests in
Stages Takashi Futami invests in
Countries Takashi Futami invests in
Investment Focus
Industry
- Medical 1 (100%)
- Biopharma 1 (100%)
- Therapeutics 1 (100%)
- Biotechnology 1 (100%)
- Bioinformatics 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Metagen Therapeutics
|
Metagen Therapeutics (MGTx) is a clinical-stage company operating Japan’s first GMP-compliant manufacturing platform for fecal microbiota transplantation (FMT) therapies. The company combines proprietary paired metagenomic datasets with AI/ML-driven donor-recipient matching to advance precision microbiome medicine across ulcerative colitis,immuno-oncology, and neurodegenerative disease. Headquartered in Tsuruoka, Japan, MGTx leverages a cross-border regulatory strategy spanning PMDA and FDA pathways, positioning it as a platform bridging Japanese clinical innovation with global market access. | $344.7K / Seed / Oct 06, 2022 |
Co-Investors
About Astellas Venture Management
Astellas Venture Management is a California-based financial organization that targets investments in the biotechnology sector.
Astellas Venture Management Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Ken Shimokawa
Senior Investment Director
|
|||
|
Takashi Futami
Associate Investment Director
|
|||
|
Takatoshi Soga
Associate Investment Director
|
|||
|
Taro Masunaga
Investment Director
|
|||
Kenji Yasukawa
President and CEO
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Takashi Futami invest in?
Takashi Futami invests primarily in Medical, Biopharma and Therapeutics startups, most often at Seed stage. Most of the 1 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Takashi Futami last invest?
The most recent investment recorded for Takashi Futami closed in Oct 2022. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
